Page 1
8
Haematology—Long Cases
Fric Tse, Yok-Lam Kwong, and Luen-Bik To
8.1 A man with fever (acute leukaemia)
History
A 45-year-old man presented with a 2-week history of fever, easy
bruising, and gum bleeding. His full blood count showed severe
anaemia, a high white cell count, and marked thrombocytope-
nia. A bone marrow biopsy was performed and acute myeloid
leukaemia was diagnosed. He was treated with combination chem-
otherapy resulting in a complete remission. He was continued on
consolidation chemotherapy but had a relapse of his leukaemia
6 months later. He was readmitted for further chemotherapy.
Physical examination
He had pallor and petechiae but no lymphadenopathy. There was
4 splenomegaly of 4 cm below the costal margin. Fundoscopic
€Xamination showed the presence of retinal haemorrhages.
Questions
‘1‘ What other information in the past history may be
Important?
* He may have had prior exposure to radiation, chemotherapy,
and toxic chemicals. He may also have a past history of
View original page (figures / layout)
Page 2
110 Problem-Based Medical Case Management Case 8.1
myelodysplastic syndrome, myeloproliferative disease or
chronic myeloid leukaemia.
2. Which type of acute leukaemia commonly affects gum
and skin?
e Acute monocytic leukaemia has a predilection to infiltrate the
gums and skin.
3. What is the percentage of blast cells in the marrow that is
required for the diagnosis of acute leukaemia?
o 20%.
4. What examinations are usually performed on the bone
marrow biopsy for a precise classification of the leukaemia?
e These include morphological examination, cytochemistry,
immunophenotyping, cytogenetics, and molecular genetic
analysis.
5. Why is it important to differentiate acute promyelo-
cytic leukaemia (APL) from the other types of acute myeloid
leukaemia?
e APL is associated with a higher risk of life-threatening bleed-
ing, especially intracranial bleeding, and therefore requires
intensive transfusion of platelets and fresh frozen plasma. APL
responds well to initial treatment with all-trans retinoic acid and
chemotherapy. Arsenate therapy is also very effective against
this leukaemia. APL is associated with a good prognosis.
6. What are the important general side effects of the chemo-
therapy given for acute leukaemia?
° These include nausea and vomiting, mucositis, diarrhoea, and
neutropenic infections.
7. What are the common causes of neutropenic infections?
* They are usually Gram negative bacterial infections. Gram
positive bacterial infection is increasingly common and is often
associated with the use of indwelling central venous catheter.
Prolonged neutropenia is commonly associated with fungal
infections. .
8. Why is haematopoietic stem cell transplantation effective in
treating acute leukaemia?
* High-dose chemotherapy/total body irradiation is used to eradi-
cate the leukaemia. Also, the T-cells in the donor haematopoietic
View original page (figures / layout)
Page 3
Case 8.2 Haematology 111
stem cells induce a graft versus leukaemia effect against resid-
ual disease that has survived the high-dose chemotherapy.
Pitfalls and tips
« Acute myeloid leukaemia has to be distinguished from acute
lymphoblastic leukaemia as the treatment is different.
+ The diagnosis of acute promyelocytic leukaemia has to be
considered if there is severe clinical bleeding. There is usually
laboratory evidence of disseminated intravascular coagulation.
+ Cytogenetics and certain somatic genetic mutations provide
very important prognostic information and are useful for decid-
ing the treatment strategy.
* Elderly patients with acute leukaemia usually have a very poor
prognosis. The leukaemia tends to be resistant to chemotherapy.
Also, old patients do not tolerate chemotherapy very well.
8.2 A woman with easy bruising (idiopathic
thrombocytopenic purpura)
History
A 40-year-old woman with good past health has presented with
a bleeding tendency including easy bruising, gum bleeding, and
menorrhagia for 1 week. She was subsequently found to have a low
platelet count. Immune thrombocytopenic purpura (ITP) was diag-
nosed and steroid therapy was commenced. However, the response
to steroid was unsatisfactory. She was admitted for splenectomy.
Physical examination
There were Cushingoid features: moon face, buffalo hump, and
truncal obesity. There were generalized petechiae. No lymphad-
enopathy and no hepatosplenomegaly were detected. The blood
pressure was normal. Fundoscopic examination was normal. Urine
glucose was negative.
View original page (figures / layout)
Page 4
112 Problem-Based Medical Case Management Case 8.2
Questions
1.
4.
What is the normal platelet lifespan?
The lifespan of platelet is normally about 7-10 days and is
reduced to 1-2 days in immune thrombocytopenic purpura.
. What are the differential diagnoses?
The differential diagnoses include causes of marrow failure
(acute leukaemia, aplastic anaemia, myelodysplastic syndrome,
and marrow infiltration by neoplastic diseases) and other causes
of increased platelet consumption (hypersplenism, dissemi-
nated intravascular coagulation, thrombotic thrombocytopenic
purpura).
. What are the expected bone marrow biopsy findings in ITP?
The bone marrow in ITP shows increased megakaryocytes, sug-
gesting a consumptive cause of thrombocytopenia.
What are the useful investigations for the purpose of exclu-
sion of disseminated intravascular coagulation (DIC)?
In DIC, there will be fragmented red cells in the peripheral
blood film, prolongation of prothrombin time and activated
partial thromboplastin time, depressed fibrinogen level, and
increased D-dimer.
. If the patient is anaemic, what is the most likely cause?
Bleeding and iron deficiency anaemia are most likely. However,
if there is evidence of haemolytic anaemia, one has to con-
sider the diagnosis of Evans syndrome (autoimmune haemo-
lytic anaemia and immune thrombocytopenia) or thrombotic
microangiopathy (microangiopathic haemolytic anaemia and
thrombocytopenia).
. What is the initial treatment strategy for ITP?
Primary causes such as drugs should be removed. Treatment
may not be necessary if the thrombocytopenia is mild (when
platelet count is more than 30 x 10°/L) and is not associated with
clinical bleeding. Otherwise, first line therapy is corticosteroid.
. What are the side effects of corticosteroid therapy?
Important side effects of corticosteroid therapy include
Cushingnoid features, hypertension, fluid retention, hypoka-
laemia, gastritis, diabetes mellitus, osteoporosis, cataract,
View original page (figures / layout)
Page 5
Case 8.2 Haematology 113
increased risk of infections especially tuberculosis, psychosis,
myopathy, and easy bruising.
. What are the indications for splenectomy in ITP?
Splenectomy is considered if the disease is refractory to steroid,
requires a high dose of steroid for the maintenance of a safe
platelet count, or relapses after responding to steroid.
. What are the risks of splenectomy?
Splenectomy is associated with surgical risks of the operation.
Also, splenectomy results in an increased risk of infection,
especially by encapsulated bacteria such as pneumococcus and
haemophilus.
10. What are the necessary precautions before and after
splenectomy?
Appropriate vaccinations are given before splenectomy.
Patients must be warned of the increased risks of infection after
the operation. Prophylactic antibiotics are often recommended,
but their precise usefulness is undefined.
Pitfalls and tips
ITP may be associated with other autoimmune diseases, such
as systemic lupus erythematosus and autoimmune haemolytic
anaemia.
Always remember drugs as causes of ITP.
Splenomegaly is usually absent in ITP.
Anti-platelet antibody test is usually not useful in confirming
the diagnosis of ITP.
Intravenous immunoglobulin therapy may cause a rapid but
transient rise in platelet count in ITP and is useful in life-threat-
ening bleeding.
Most patients with [TP respbnd to steroid therapy but relapse is
common, especially when steroid treatment is stopped.
Azathioprine may be used as a steroid sparing agent in patients
having a response to steroid. Neutropenia is a possible side
effect, and azathioprine should not be used together with
allopurinol.
About 75% of the ITP may respond to splenectomy.
View original page (figures / layout)
Page 6
114 Problem-Based Medical Case Management Case 8.3
» Thrombopoietin receptor agonists such as eltrombopag (orally
every day) and romiplostim (subcutaneously every week) have
been shown to be very effective in steroid refractory ITP and
cases not responding to splenectomy.
¢ Other treatment strategies, such as with danazol, cyclophos-
phamide, cyclosporine, anti-CD20, and anti-CD52 monoclonal
antibodies, have been shown to be useful in some refractory
cases of ITP.
8.3 Bone pain with anaemia (multiple myeloma)
History
A 70-year-old woman presenting with back pain was diagnosed to
have multiple myeloma. While receiving chemotherapy, she com-
plained of progressive bilateral lower limb weakness. There was
also urinary and bowel incontinence.
Physical examination showed that there was mild pallor. There
was paraplegia with increased tone and brisk reflexes in the lower
limbs. The plantar responses were extensor bilaterally.
Questions
1. What are the complications of multiple myeloma?
« These include bone destruction, renal failure, bone marrow
failure, bacterial infection, hypercalcaemia, and occasionally
hyperviscosity syndrome.
. What complication has developed in this patient?
Spinal cord compression from vertebral collapse fracture.
. What should be the immediate management for this patient?
Urgent decompression spinal surgery or radiotherapy should be
considered.
. Why is renal failure common in multiple myeloma?
e Contributing factors may include obstruction of distal renal
tubules by protein casts, toxic effect of light chain on renal
LRSI
-
View original page (figures / layout)
Page 7
Case 8.3 Haematology 115
tubules, deposition of light chain in renal glomeruli, amyloidosis,
infection, hypercalcaemia, dehydration, and hyperuricaemia.
5. Why are multiple myeloma patients more prone to infection?
+ Contributing factors may include impaired B-cell function and
neutropenia.
6. What types of infection are common in multiple myeloma?
+ Encapsulated bacterial infection such as pneumococcus and
haemophilus.
7. What are the common symptoms of hypercalcaemia?
* Polyuria, polydipsia, anorexia, vomiting, lethargy, stupor or
coma.
8. What are the common symptoms of the hyperviscosity
syndrome?
» Heart failure, bleeding tendency, dizziness, somnolence, and
coma.
9. What are the typical haematological findings in multiple
myeloma?
* Normochromic and normocytic anaemia (sometimes macro-
cytic due to formation of red cell rouleaux), marked rouleaux
formation on blood film, with neutropenia and thrombocyto-
penia. There may be a leucoerythroblastic blood picture. The
erythrocyte sedimentation rate can be very high (commonly
> 80 mm in the first hour).
10. What are the important diagnostic features of multiple
myeloma?
* These include monoclonal paraprotein in serum and/or mono-
clonal free light chains in urine, the presence of discrete lytic
bone lesions, and monoclonal plasma cell proliferation in the
bone marrow.
11. What are the different treatment options for multiple
myeloma?
* Asymptomatic patients with smouldering disease may require
no treatment until there is disease progression.
* The standard treatment comprises a combination of a protea-
some inhibitor (bortezomib), an immunomodulatory drug
(thalidomide or lenalidomide), and dexamethasone. Other drug
View original page (figures / layout)
Page 8
116 Problem-Based Medical Case Management Case 8.3
combinations are also used depending on the age and physical
fitness of the patients. Radiotherapy is very effective for treat-
ing local disease and for pain control. Supportive treatment
includes transfusion, antibiotics and pain control, plasmapher-
esis for hyperviscosity syndrome, and management of hyper-
calcaemia. Bisphosphonate is commonly given to reduce bone
pain and retard the progression of bone lesions. Autologous
haematopoietic stem cell transplantation is not curative but
may provide a more prolonged control of the disease and is the
standard of care for transplant-eligible patients. Most patients
will still eventually relapse. Allogeneic haematopoietic stem
cell transplantation may provide a cure for multiple myeloma,
but the procedure-related mortality is high, and is thus reserved
only for young patients with adverse cytogenetic features and
poor response to autologous transplant, and with HLA compat-
ible donors.
Pitfalls and tips
* Spinal cord compression may complicate multiple myeloma.
‘It is an emergency and must be recognized and diagnosed early
to minimize irreversible neurological damage. Patients may
present with an acute onset of paraplegia. Urinary and bowel
incontinence may also be present.
* Multiple myeloma has to be distinguished from monoclo-
nal gammopathy of undetermined significance. In the latter,
a serum paraprotein is present. However, patients are usually
asymptomatic, and typical features of multiple myeloma,
such as anaemia, lytic bone lesions, renal function impairment,
and hypercalcaemia are absent. Monoclonal gammopathy of
undetermined significance does not require any specific treat-
ment. Furthermore, patients with lymphoproliferative disease
or lymphomas may also have paraproteinaemia.
View original page (figures / layout)